Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device

The necessity for bone marrow aspiration and the lack of highly sensitive assays to detect residual disease present challenges for effective management of multiple myeloma (MM), a plasma cell cancer. We show that a microfluidic cell capture based on CD138 antigen, which is highly expressed on plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Qasaimeh, Mohammad A., Wu, Yichao C., Bose, Suman, Menachery, Anoop, Talluri, Srikanth, Gonzalez, Gabriel, Fulciniti, Mariateresa, Karp, Jeffrey M., Prabhala, Rao H., Karnik, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379479/
https://www.ncbi.nlm.nih.gov/pubmed/28374831
http://dx.doi.org/10.1038/srep45681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379479/
https://www.ncbi.nlm.nih.gov/pubmed/28374831
http://dx.doi.org/10.1038/srep45681

Ejemplares similares